Follow
Barbara Sanchez-Dengra
Barbara Sanchez-Dengra
Verified email at umh.es
Title
Cited by
Cited by
Year
Recent developments in cancer therapy and diagnosis
E Atlihan-Gundogdu, D Ilem-Ozdemir, M Ekinci, E Ozgenc, ES Demir, ...
Journal of pharmaceutical investigation 50, 349-361, 2020
392020
In Vitro Dissolution as a Tool for Formulation Selection: Telmisartan Two-Step IVIVC
MT Martinez-Martinez, S Colon-Useche, B Sanchez-Dengra, R Iriarte, ...
34*
Candesartan cilexetil in vitro–in vivo correlation: predictive dissolution as a development tool
A Figueroa-Campos, B Sánchez-Dengra, V Merino, A Dahan, ...
Pharmaceutics 12 (7), 633, 2020
222020
Oral controlled release dosage forms: dissolution versus diffusion
M Bermejo, B Sanchez-Dengra, M Gonzalez-Alvarez, I Gonzalez-Alvarez
Expert Opinion on Drug Delivery 17 (6), 791-803, 2020
222020
In vitro model for predicting the access and distribution of drugs in the brain using hCMEC/D3 cells
B Sánchez-Dengra, I González-Álvarez, F Sousa, M Bermejo, ...
European Journal of Pharmaceutics and Biopharmaceutics 163, 120-126, 2021
192021
Access to the CNS: Strategies to overcome the BBB
B Sánchez-Dengra, I González-Álvarez, M Bermejo, M González-Álvarez
International Journal of Pharmaceutics 636, 122759, 2023
122023
Two-step in vitro-in vivo correlations: Deconvolution and convolution methods, which one gives the best predictability? Comparison with one-step approach
B Sánchez-Dengra, I González-García, M González-Álvarez, ...
European Journal of Pharmaceutics and Biopharmaceutics 158, 185-197, 2021
82021
Comparative analysis of milk triglycerides profile between jaffarabadi buffalo and holstein friesian cow
A Verma, NS Meitei, PU Gajbhiye, MJ Raftery, K Ambatipudi
Metabolites 10 (12), 507, 2020
72020
Nanomedicine in the Treatment of Pathologies of the Central Nervous System
B Sánchez-Dengra, I González-Álvarez, M Bermejo, M González-Álvarez
Advances in Nanomedicine, 2020
7*2020
pH-Dependent Molecular Gate Mesoporous Microparticles for Biological Control of Giardia intestinalis
I Gonzalez-Alvarez, V Vivancos, C Coll, B Sánchez-Dengra, E Aznar, ...
Pharmaceutics 13 (1), 94, 2021
52021
Physiologically based pharmacokinetic (Pbpk) modeling for predicting brain levels of drug in rat
B Sánchez-Dengra, I Gonzalez-Alvarez, M Bermejo, M Gonzalez-Alvarez
Pharmaceutics 13 (9), 1402, 2021
42021
New In Vitro Methodology for Kinetics Distribution Prediction in the Brain. An Additional Step towards an Animal-Free Approach
B Sánchez-Dengra, I González-Álvarez, M González-Álvarez, M Bermejo
Animals 11 (12), 3521, 2021
32021
Formulaciones para la cicatrización de heridas, presente y futuro
AL Arranz, BS Dengra, MVB Sanz, IG Álvarez, MG Álvarez
RESCIFAR Revista Espańola de Ciencias Farmacéuticas 2 (1), 1-12, 2021
32021
Exploring a bioequivalence failure for silodosin products due to disintegrant excipients
I González-Álvarez, B Sánchez-Dengra, R Rodriguez-Galvez, ...
Pharmaceutics 14 (12), 2565, 2022
12022
Marine-based biopolymers for central nervous system drug delivery
B Sánchez-Dengra, M Bermejo, I González-Álvarez, M González-Álvarez
Marine Biomaterials: Drug Delivery and Therapeutic Applications, 317-349, 2022
12022
Alternative methodology for the study of brain distribution of drugs with in vitro tests.
B Sanchez-Dengra, I Gonzalez-Alvarez, M Gonzalez-Alvarez, M Bermejo
2024
In silico, in situ, in vitro, and in vivo predictive methods for modeling formulation performance
M Bermejo, I Camara-Martinez, B Sanchez-Dengra, A Ruiz-Picazo, ...
From Current to Future Trends in Pharmaceutical Technology, 67-116, 2024
2024
Intranasal administration of molecular-gated mesoporous nanoparticles to increase ponatinib delivery to the brain
B Sánchez-Dengra, M Alfonso, I González-Álvarez, M Bermejo, ...
Nanomedicine 18 (25), 1799-1813, 2023
2023
Establishment and Validation of a New Co-Culture for the Evaluation of the Permeability through the Blood–Brain Barrier in Patients with Glioblastoma
B Sánchez-Dengra, E García-Montoya, I González-Álvarez, M Bermejo, ...
Pharmaceutics 15 (5), 1431, 2023
2023
Uso de co-cultivos para valorar el acceso de fármacos al cerebro en presencia de glioblastoma
BS Dengra, EG Montoya, IG Alvarez, MG Alvarez, MVB Sanz
XVI Congreso SEFIG (16. 2023. Madrid): Libro de comunicaciones, 283-284, 2023
2023
The system can't perform the operation now. Try again later.
Articles 1–20